Aktive Positionen von Andrew Luber
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Virion Therapeutics LLC
 Virion Therapeutics LLC BiotechnologyHealth Technology Virion Therapeutics LLC develops chronic viral disease vaccines. It offers ChiVax and ChiVax-gD vaccines. The firm engages in developing immune-based treatments for virally-associated cancers and chronic viral infections. The company was founded by Bernard C. Rudnick, Hildegund C. J. Ertl and Andrew D. Luber in 2018 and is headquartered in Newark, DE. | Direktor/Vorstandsmitglied | 30.10.2020 | - |
| Vorstandsvorsitzender | 30.10.2020 | - | |
| Gründer | 01.01.2018 | - | |
| Präsident | 30.10.2020 | - |
Karriereverlauf von Andrew Luber
Statistik
International
| Vereinigte Staaten | 2 |
Operativ
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Founder | 1 |
Sektoral
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Virion Therapeutics LLC
Virion Therapeutics LLC BiotechnologyHealth Technology Virion Therapeutics LLC develops chronic viral disease vaccines. It offers ChiVax and ChiVax-gD vaccines. The firm engages in developing immune-based treatments for virally-associated cancers and chronic viral infections. The company was founded by Bernard C. Rudnick, Hildegund C. J. Ertl and Andrew D. Luber in 2018 and is headquartered in Newark, DE. | Health Technology |
- Börse
- Insiders
- Andrew Luber
- Erfahrung
